Differential Regulation of Simultaneous Antitumor and Alloreactive CD8+ T-Cell Responses in the Same Host by Rapamycin
Article first published online: 25 OCT 2011
©Copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 12, Issue 1, pages 233–239, January 2012
How to Cite
Vareki, S. M., Harding, M. J., Waithman, J., Zanker, D., Shivji, A. N., Rytelewski, M., Mazzuca, D. M., Yekta, M. A., Chen, W., Schell, T. D. and Haeryfar, S. M. M. (2012), Differential Regulation of Simultaneous Antitumor and Alloreactive CD8+ T-Cell Responses in the Same Host by Rapamycin. American Journal of Transplantation, 12: 233–239. doi: 10.1111/j.1600-6143.2011.03811.x
- Issue published online: 13 JAN 2012
- Article first published online: 25 OCT 2011
- Received 20 April 2011, revised and accepted for publication 02 September 2011
Figure S1: Depicts a head-to-head comparison of ICS for IFN-γ and tetramer staining for detection of site I- and site IV-specific TCD8 at the peak of their primary response.
Figure S2: Demonstrates the effect of continuous rapamycin treatment on long-term frequencies of T Ag-specific and alloreactive TCD8.
|AJT_3811_sm_FiguresS1-S2.ppt||798K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.